MYCN and neuroblastoma: The results showed that UNC0642 consistently and dose-dependently reduced cell viability in both SH-SY5Y (MYCN single copy) and SK-N-Be(2) (MYCN-amplified) NB cells, as well as SK-ES1 and RD-ES ES cells (Figure 6A–D).